Table III.

The clinical parameters of patients with GC and GC tumors.

Sample	Sex	Age (years)	Differentiateda	TNM stagingb	Depth of invasion	LN metastasis
1	Male	58	MDACc	IIIB	T3	N2
2	Male	74	PDAC	II	T3	N0
3	Female	79	PDAC	III	T3	N2
4	Female	76	PDAC	IIIB	T3	N2
5	Male	73	MDAC	IV	T3	N3
6	Male	87	MDAC	IA	T1	N0
7	Female	71	MDAC	IV	T4	N2
8	Male	73	MDAC	II	T2	N1
9	Male	57	PDAC	IB	T2	N0
10	Female	34	PDAC	IA	T1	N0
11	Male	75	PDAC	IIIB	T3	N2
12	Male	54	MDAC	IB	T2	N0
13	Female	70	PDAC	IV	T3	N3
14	Male	62	MDAC	II	T2	N1
15	Female	67	MDAC	IV	T4	N2
16	Male	26	MDAC	IIIA	T3	N1
17	Female	45	MDAC	IIIB	T3	N2
18	Male	59	PDAC	IV	T3	N3a
19	Male	50	MDAC	II	T2	N1
20	Male	52	MDAC	IV	T4a	N3b
21	Female	42	MDAC	II	T3	N0
22	Female	67	MDAC	IIIB	T3	N2
23	Female	41	PDAC	IV	T4a	N3b
24	Male	53	MDAC	IIIB	T3	N2
25	Male	46	PDAC	IV	T4a	N3b
26	Female	34	PDAC	IB	T2	N0

Mean age, 59 years; age range, 26–87 years.

^aWorld Health Organization classification of tumors of the digestive system (17).

^bThe American Joint Committee on Cancer staging system (18).

^cMucinous carcinoma and poorly differentiated adenocarcinoma were classified into a group due to the analogously poor prognosis. TNM, Tumor-Node-Metastasis; LN, lymph node; PDAC, poorly-differentiated adenocarcinoma; MDAC, moderately-differentiated adenocarcinoma; WDAC, well-differentiated adenocarcinoma.